ELIZABETH KOZLOWSKI: Open Payments
NPI 1104804285 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 66 payments from 15 companies in 2025. Trend: 2023 $1,005 · 2024 $954 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $510 |
| Novo Nordisk Inc | 23 | $491 |
| ABBVIE INC. | 13 | $296 |
| PFIZER INC. | 4 | $93 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| IBSA Pharma Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Indivior Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Ozempic, AIRSUPRA, BREZTRI, FARXIGA, VRAYLAR, QULIPTA, Rybelsus, Wegovy.
Industry payments across MI — which companies pay providers there.
